New Products In Brief
This article was originally published in The Tan Sheet
Executive Summary
Glucosamine Rx drug: Zylera Pharmaceuticals' Rx drug RELAMINE (glucosamine 400 mg, chondroitin 300 mg and primorine 425 mg) is now available throughout the U.S., the company announces Jan. 25. The Research Triangle Park, N.C.-based firm says the product helps "reduce joint swelling and control pain while slowing the onset and progression of osteoarthritis." The product is "indicated for the distinct nutritional requirements of individuals under a physician's treatment for osteoarthritis," according to a package insert. The NIH-sponsored GAIT trial following 1,583 participants found those with moderate-to-severe osteoarthritis experienced significant pain reduction when taking the supplements glucosamine and chondroitin (1"The Tan Sheet," Feb. 27, 2006, p. 5)...